期刊文献+

端粒酶反义寡聚脱氧核苷酸对子宫内膜癌细胞株的影响

Effect of telomerase antisense oligodeoxynucleotide on endometrial carcinoma cell strain
暂未订购
导出
摘要 目的观察端粒酶反义寡聚脱氧核苷酸对癌细子宫内膜癌细胞株的作用。方法用端粒酶反义寡聚脱氧核苷酸与子宫内膜细胞株共同温育一定时间后,观察细胞形态变化,检测细胞Bcl-2蛋白表达情况,测定端粒酶活性。结果端粒酶反义寡聚脱氧核苷酸能诱导子宫内膜癌细胞凋亡,抑制端粒酶活性,在形态学上表现为出现细胞质浓缩,变圆,核染色不均匀,核物质边聚成新月形或块壮;电泳呈凋亡特征性Ladder带;流式细胞仪分析显示,反义寡核苷酸在细胞进入DNA合成期前引起DNA损伤,使细胞停滞在G0~G1期,并诱导细胞凋亡。结论端粒酶反义寡聚脱氧核苷酸能抑制端粒酶活性,诱导子宫内膜癌细胞凋亡,从而抑制子宫内膜癌的增殖。 Objective To observe the effect of telomerase antisense oligodeoxynucleotide on endometrial carcinoma cell strain.Methods After endometrial carcinoma cell strain was incubated with telomerase antisense oligodeoxynucleotide for a certain time,the changes of cell morphous were observed,and the expression levels of bcl-2 protein and telomerase's activity were detected.Results Telomerase antisense oligodeoxynucleotide could induce the apoptosis of endometrial carcinoma cells and could inhibit telomerase activity.The observation for cell morphous showed that cells became round shape,cytoplasm was condensed,without uniform nuclear staining,with crescent or lump form nuclear matter as well as the apoptosis characteristic Ladder bands showed by electrophoresis.Flow cytometry analysis revealed that antisense oligodeoxynucleotide could cause DNA damage before the cells were differentiated into DNA synthesis period,as a result,which resulted in the stagnation of cells at G0-G1 phase,and induced cell apoptosis.Conclusion Telomerase antisense oligodeoxynucleotide can inhibit telomerase's activity and can induce the apoptosis of endometrial carcinoma cell,as a result,which can inhibit the proliferation of endometrial carcinoma cell.
出处 《河北医药》 CAS 2012年第17期2576-2579,共4页 Hebei Medical Journal
关键词 端粒酶 子宫内膜癌细胞 反义寡聚脱氧核苷酸 凋亡 telomerase endometrial carcinoma cells antisense oligodeoxynucleotide apoptosis
  • 相关文献

参考文献7

  • 1王红军,陈琼,于洪涛.端粒酶RNA的反义寡核苷酸抑制裸鼠移植瘤生长的研究[J].中国肺癌杂志,2008,11(2):198-201. 被引量:5
  • 2曾益新主编.肿瘤学.第1版.北京:人民卫生出版社,2001.242.
  • 3Walton SP,Stephanopoulos GN,Yarmush ML,et al. Thermodynamic andkinetic-characterization of oligodexynucleotide binding to a structuredmRNA. J Biophys ,2002,82 :366-377.
  • 4Zhao YM,Li JY,Lan JP,et al. Cell cycle dependent te-lomere regulationby telomerase in human bone marrow mesenchymal stem cells. BiochemBiophys Res Commun,2008 ,369 : 1114-1119.
  • 5Bermudez Y, Grasso D, John NC, et al. Telomerase con-fers resistance tocaspase-mediated apoptosis. Clin Inter Aging,2006,1 : 155-167.
  • 6Shammas MA, Koley H, Bertheau RC, et al. Telomerase inhibitorGRN163 L inhibits myeloma cell growth in vitro and invivo. Leukemia,2008,22:1410-1418.
  • 7Chen Z, Koeneraan KS, Corey DR. Consequences of telomerase in-hibitionand combination treatments for the proliferation of cancer cells. CancerRes,2005 ,63 :5917-5925.

二级参考文献15

  • 1Hsu CP,Miaw J,Shai SE,et al.Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer-an adjustedmeasurement and its clinical significance.Eur J Cardiothorac Sur.2004,26:425-431.
  • 2Zaffaroni N,De Polo D,Villa R,et al.Differential expression of telomerase activity in neuroendocrine lung tumors correlation with gene product immunophenotyping.J Pathol,2003,201(1):127-133.
  • 3Fumiyuki K,Toshiaki K,Sadayuki H.Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas.Hum Pathol,2001,32(2):188-195.
  • 4Kiyoshi S,Takehiko F,Hidehisa H,et al.Increased telomerase activity and elevated hTERT mRNA expression during multistage carcinogenesis of squamous cell carcinoma of the lung.Cancer,2001,92(4):849-855.
  • 5Kondo S,Kondo Y,Li G,et al.Targeted therapy of human malignant glioma in a mouse model by 2-5A-antisense directed against telomerase RNA.Oncogene,1998,16(25):3323-3330.
  • 6Shen M,Feng YJ,Zhou XR,et al.Effects of liposome CerbB-2 antisense oligodeoxynucleotide on the human ovarian epithelial cancer transplanted subcutaneously in nude mice.Curr Adv Obstet Gynecol,1998,7(4):314-316.[沈梅,丰有吉,周先荣,等.脂质体-CerbB-2反义寡核苷酸对卵巢上皮癌裸鼠皮下移植瘤的作用,现代妇产科进展,1998,7(4):314-316.
  • 7Hiyama E,Hiyama K.Telomerase as tumor marker.Cancer Lett,2003,194(2):221-233.
  • 8Soretzki G.Telomerase inhibition as cancer therapy.Cancer Lett,2003,194(2):209-219.
  • 9Kondo Y,Koga S,Komata T,et al.Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.Oncogene,2000,19(18):2205-2211.
  • 10Lledo S,Alfonso R,Aliii SF,et al.Antisense gene therapy using anti-k-ras and antitelomerase olignucleotides in colorectal cancer.Rev Esp Enferm Dig,2005,97(7):472-480.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部